Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Contract Research & Services
Return to: PBR Home | Contract Research & Services
Today in Contract Research & Services

Contract Research & Services

Pfizer, Merck to jointly develop and commercialize new cancer treatments Pfizer has entered into an agreement with Merck to jointly develop and commercialize MSB0010718C, an investigational anti-PD-L1 antibody being developed by Merck as a potential treatment for several types of cancer. Contract Research & Services > Contract Services > News

Latest Contract Research & Services News by Sector

Select a sector from the list or browse by sector below:

Clinical Trials

Amgen terminates all company-sponsored trials of rilotumumab in advanced gastric cancer
By PBR Staff Writer
Amgen has terminated all of the company-sponsored clinical trials of rilotumumab, an investigational fully-human monoclonal antibody, in advanced gastric cancer including the Phase III RILOMET-1 and RILOMET-2 trials.
News
Xenetic completes dosing patients in Phase II MyeloXen trial to treat multiple sclerosis
By PBR Staff Writer
Xenetic Biosciences' license partner Pharmsynthez has completed dosing patients in its Phase II clinical trial with MyeloXen to treat relapsing remitting and secondary progressive (RRSP) multiple sclerosis (MS).
News

Contract Research

Nuvilex forms Diabetes consortium to develop treatment for Insulin-Dependent Diabetes
Nuvilex, a clinical-stage biotechnology company providing cell therapy solutions for the treatment of diseases, has formed a 'Diabetes Consortium' that will be tasked with the development of Nuvilex's treatment for insulin-dependent diabetes.
News
Transposagen enters into research collaboration with Janssen for Allogeneic CAR T-Cell therapies
Transposagen Biopharmaceuticals, a private biotechnology company headquartered in Lexington, KY, they have entered into a research collaboration and worldwide license agreement with Janssen Biotech (Janssen) to develop allogeneic Chimeric Antigen Receptor T-cells (CAR-T).
News

Contract Services

Paragon wins NIH contract to design and scale-up manufacturing of rhE-Selectin protein
Paragon Bioservices has been awarded a contract from the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke to design and establish a scale-up manufacturing process for the cGMP production of the recombinant human rhE-selectin protein.
News
Merck, NewLink Genetics ink licensing deal for investigational Ebola vaccine
By PBR Staff Writer
Merck and NewLink Genetics have entered into an exclusive worldwide license agreement to research, develop, manufacture and distribute NewLink’s investigational rVSV-EBOV (Ebola) vaccine candidate.
News